Lv1
80 积分 2026-03-01 加入
Tiragolumab plus atezolizumab and chemotherapy as first-line treatment for patients with unresectable oesophageal squamous cell carcinoma (SKYSCRAPER-08): a randomised, double-blind, placebo-controlled, phase 3 trial
5小时前
待确认
Brusatol: A potential sensitizing agent for cancer therapy from Brucea javanica
1个月前
已完结
皖公网安备34019202002308
